Relationship Between Low-Dose Aspirin-Induced Gastric Mucosal Injury and Intragastric pH in Healthy Volunteers

Background and Aims Gastric acid plays an important role in the pathogenesis of gastric mucosal lesions. We investigated whether aspirin-induced gastric mucosal injury might have any association with the intragastric pH. Materials and Methods Fifteen healthy, Helicobacter pylori -negative volunteers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Digestive diseases and sciences 2010-06, Vol.55 (6), p.1627-1636
Hauptverfasser: Nishino, Masafumi, Sugimoto, Mitsushige, Kodaira, Chise, Yamade, Mihoko, Shirai, Naohito, Ikuma, Mutsuhiro, Tanaka, Tatsuo, Sugimura, Haruhiko, Hishida, Akira, Furuta, Takahisa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Aims Gastric acid plays an important role in the pathogenesis of gastric mucosal lesions. We investigated whether aspirin-induced gastric mucosal injury might have any association with the intragastric pH. Materials and Methods Fifteen healthy, Helicobacter pylori -negative volunteers randomly underwent the four different 7-day regimens: (1) aspirin 100 mg, (2) rabeprazole 10 mg, (3) aspirin 100 mg + rabeprazole 10 mg, and (4) aspirin 100 mg + rabeprazole 40 mg. Gastric mucosal injury based on the modified Lanza score (MLS), 24-h intragastric pH, and histopathology of gastric mucosa were evaluated prior to the start and on day 7 of each regimen. Results The median MLSs were 0 in the baseline and the rabeprazole 10 mg regimen. The median MLS in the aspirin regimen was 3, while those in both aspirin + rabeprazole 10 mg and aspirin + rabeprazole 40 mg regimens were 0. Rabeprazole significantly prevented the gastric mucosal injury by aspirin ( P  = 0.001 for rabeprazole 10 mg and P  = 0.005 for rabeprazole 40 mg). The MLSs were negatively correlated with the 24-h intragastric pH ( P  = −0.711,
ISSN:0163-2116
1573-2568
DOI:10.1007/s10620-009-0920-3